33 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-ß hydrolysis.

University of Lille
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite.

Glaxosmithkline
Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensives.

Rorer Central Research
Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.

TBA
Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogues: potent angiotensin converting enzyme inhibitors.

TBA
Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(Mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acids.

TBA
Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme by N-phosphonomethyl and N-carboxyalkyl dipeptides

TBA
4-Substituted proline derivatives that inhibit angiotensin converting enzyme and neutral endopeptidase 24.11.

TBA
Phage-encoded combinatorial chemical libraries based on bicyclic peptides.

Laboratory of Molecular Biology, Medical Research Council
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by tricyclic benzazepinone thiols

TBA
α-Mercaptoacyl dipeptides that inhibit angiotensin converting enzyme and neutral endopeptidase 24.11

TBA
Peptide mimics of glycylproline as inhibitors of prolidase

TBA
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite.

Glaxosmithkline
The evolution of small molecule enzyme activators.

University of Nebraska
Structure-Guided Chemical Optimization of Bicyclic Peptide (

Bicycletx
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China.

Qufu Normal University
Thorectidiol A Isolated from the Marine Sponge

University of British Columbia
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.

Shandong University
The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.

American University of Ras Al Khaimah
Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection.

Kingston University
Discovery of honokiol thioethers containing 1,3,4-oxadiazole moieties as potential α-glucosidase and SARS-CoV-2 entry inhibitors.

Zhengzhou University
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein.

University of Groningen
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.

University of California San Francisco (Ucsf)
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases.

Qpex Biopharma
The Other Angiotensin II Receptor: AT

Centre Hospitalier Universitaire Vaudois (Chuv) and University of Lausanne (Unil
Angiotensin converting enzyme inhibitors: modifications of a tripeptide analogue.

TBA
The first mechanism-based inactivators for angiotensin-converting enzyme.

Baxter Diagnostics
Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators

Genentech
Bicyclic lactams and methods of use thereof

Genentech
Thiazolidinone compounds and use thereof

National Health Research Institute
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Array Biopharma
Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design.

Vernalis (R&D)
Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysis.

Glaxosmithkline